✓
Open
16 Jun 2023
✓
Close
21 Jun 2023
3
Allotment
—
✓
Listing
Fri, Jun 30, 2023
Price Band
₹30 per share
Issue Size
40,00,000 shares (agg. up to ₹12 Cr)
Lot Size
4,000 Shares
Listing Date
Fri, Jun 30, 2023
Latest GMP
₹0
Est. Gain
1%
✦ AI Insight
GMP Trend
30-06-2023₹0Est. ₹30+1%
29-06-2023₹0Est. ₹30+1%
28-06-2023₹0Est. ₹30+1%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 2.75x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Dec 2022 | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|---|
| Assets | 16.87 | 13.56 | 13.89 | 14.01 |
| Total Income | 9.03 | 11.22 | 11.72 | 16.82 |
| Profit After Tax | 1.28 | 0.03 | 0.12 | 0.16 |
| NET Worth | 8.68 | 7.40 | 7.36 | 7.24 |
| Reserves and Surplus | 5.38 | 4.10 | 4.06 | 3.94 |
| Total Borrowing | 6.18 | 5.30 | 5.52 | 4.53 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Remus Pharmaceuticals Ltd. | SME | ₹47.69 Cr | ₹1229 | 21.09 | ₹1,796.80 | +46.20% | ₹734.10 (-0.45%) |
| Infinium Pharmachem Ltd. | SME | ₹25.25 Cr | ₹135 | 7.83 | ₹147.80 | +9.48% | ₹209.50 (+1.67%) |
| Sotac Pharmaceuticals Ltd. | SME | ₹33.30 Cr | ₹111 | 132.14 | ₹120.75 | +8.78% | ₹95.10 (-4.90%) |
| Trident Lifeline Ltd. | SME | ₹35.34 Cr | ₹101 | 51.53 | ₹108.15 | +7.08% | ₹259.75 (-0.44%) |
| Dipna Pharmachem Ltd. | SME | ₹15.21 Cr | ₹38 | 39 | ₹33.40 | -12.11% | ₹5.35 (-0.93%) |
| JFL Life Sciences Ltd. | SME | ₹18.17 Cr | ₹61 | 26.52 | ₹66.50 | +9.02% | ₹10.50 (-4.55%) |
| Mankind Pharma Ltd. | Mainboard | ₹4,326.36 Cr | ₹1080 | 32.5 | ₹1,080.00 | +0.00% | ₹2,484.20 (-2.10%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Augmenting additional working capital requirements | 8.49 |
| 2 | General Corporate Purposes | 2.51 |
About Vilin Bio Med IPO
Incorporated in 2005, Vilin Bio Med Limited is engaged in the domestic business of manufacturing pharmaceutical products, and the manufacturing unit. The company sells its products in bulk to pharmaceutical manufacturers, marketers, and traders, who provide the channel for sales to customers. Its product list can be classified into: Oral Liquid (Syrups/Suspensions/Dry Powders (βeta & Non-βeta-Lactam). Tablets & Capsules (βeta & Non-βeta-Lactam). External Preparations. Dry Powders. The company has its R&D foundation and manufacturing facility in Roorkee, Uttarakhand. Vilin Bio Med recorded a Rs. 1,121.91 Lakhs revenue in the year 2022, and Rs. 1,171.88 Lakhs in the year 2021.+ Read More
Contact Details
Vilin Bio Med Ltd. AddressSy.No.115/GF/JHanumanji Colony, Brig Sayeed RoadBowempallySecunderabad, Telangana, 500003+91 40 7961 8843cs@vilinbiomed.co.inVisit Website